Corrigendum to “Safety and efficacy of self-assembling bubble carriers stabilized with sodium dodecyl sulfate for oral delivery of therapeutic proteins” [Journal of Controlled Release, Volume 259, pp. 168–175, (2017), doi: 10.1016/j.jconrel.2016.12.018]

  • Po Yen Lin
  • , Er Yuan Chuang
  • , Yi Hsuan Chiu
  • , Hsin Lung Chen
  • , Kun Ju Lin
  • , Jyuhn Huarng Juang
  • , Ching Hua Chiang
  • , Fwu Long Mi*
  • , Hsing Wen Sung
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

In Fig. 4 [Figure Presented] in the original publication, there was an inadvertent duplication of images. In Fig. 4A: the image for LD SDS was a duplication of the image for Normal and in Fig. 4B: the image for HD SDS was a duplication of the image for MD SDS. The corrected images, obtained from original data, are included below. These changes do not affect the interpretation of the data or the conclusion of the study. In Fig. 5B[Figure Presented], there were three test rats in each group. An IVIS image (FITC-LPS, the bottom row) in the HD SDS group (the first group from the right) that was obtained from another rat in the same group was incorporated in the figure. It would be more appropriate if the IVIS images (Cy5-Insulin and FITC LPS) that were taken from the same rat are used, like the other three control groups (w/o SDS, LD SDS, and MD SDS). These changes do not affect the interpretation of the data or the conclusion of the study.

Original languageEnglish
Pages (from-to)764-766
Number of pages3
JournalJournal of Controlled Release
Volume362
DOIs
StatePublished - 10 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022 Elsevier B.V.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Corrigendum to “Safety and efficacy of self-assembling bubble carriers stabilized with sodium dodecyl sulfate for oral delivery of therapeutic proteins” [Journal of Controlled Release, Volume 259, pp. 168–175, (2017), doi: 10.1016/j.jconrel.2016.12.018]'. Together they form a unique fingerprint.

Cite this